Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The combination of chemoimmunotherapy with a targeted drug represents a step toward a new standard of care for people with CLL.
Thousands of people around the world have already received the promising new therapy.
You may know the struggle of maintaining a healthy and well-balanced diet due to the limited time, energy, or resources you have available.
Can new therapies benefit patients with early stage melanoma, where spread of disease has yet to be observed?
An overactive immune system is the main reason that many people with both cancer and autoimmune diseases aren’t included in clinical trials.
It was generally younger, healthier women who chose to have combined breast and gynecologic surgeries.
An interview with Michael Kaplan, president and CEO of the Melanoma Research Alliance, about curing the deadliest skin cancer
Getting relief from stress and pain by imagining that you’re somewhere else
For patients, the decision to move forward with adjuvant therapy isn’t as cut and dry as it may seem.
The 60-plus year-old drug, a mainstay of treatment for many cancers, acts as chemotherapy and immunotherapy at high doses, a study finds.
As a rural town grapples with the closure of its hospital, cancer patients try to continue their treatments in different locations.
The study results, which have been presented at scientific meetings, are already a matter of debate among oncologists.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.